XBiotech XBIT
NASDAQ XBIT
$2.31 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

XBiotech (XBIT) Receivables - Other (2022 - 2026)

XBiotech (XBIT) posted quarterly Receivables - Other of $360000.0 for Q4 2025, down 48.57% year-over-year from $700000.0 in Q4 2024, and down 48.57% quarter-over-quarter from $700000.0 in Q4 2024.

XBiotech (XBIT) Receivables - Other (2022 - 2026) Analysis & Trends

XBiotech's Receivables - Other history runs 4 years deep, the most recent figure standing at $360000.0 for Q4 2025.

  • In Q4 2025, Receivables - Other fell 48.57% year-over-year to $360000.0; the TTM figure through Dec 2025 stood at $360000.0 (down 48.57% YoY), while the FY2025 annual figure was $360000.0, down 48.57% from the prior year.
  • Receivables - Other for Q4 2025 stood at $360000.0, down from $700000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $3.2 million in Q2 2023, with the low at $360000.0 in Q4 2025.
  • The 4-year median for Receivables - Other is $1.0 million (2022), against an average of $1.5 million.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other fell 18.6% in 2024, then tumbled 48.57% in 2025.
  • XBiotech's Receivables - Other stood at $1.2 million in 2022, then declined by 29.28% to $860000.0 in 2023, then dropped by 18.6% to $700000.0 in 2024, then sank by 48.57% to $360000.0 in 2025.
  • Business Quant data shows XBIT's Receivables - Other at $360000.0 in Q4 2025, $700000.0 in Q4 2024, and $860000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 XBiotech 68.90 Mn 68.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 277,000.00
Jun 30, 2026 277,000.00
Dec 31, 2025 360,000.00
Dec 31, 2025 360,000.00
Dec 31, 2024 700,000.00
Dec 31, 2024 700,000.00
Dec 31, 2023 860,000.00
Dec 31, 2023 860,000.00
Jun 30, 2023 3.22 Mn
Jun 30, 2023 3.22 Mn
Mar 31, 2023 2.37 Mn
Mar 31, 2023 2.37 Mn
Dec 31, 2022 1.22 Mn
Dec 31, 2022 1.22 Mn